Are you or do you know a Survivor of a pediatric brain tumour, who is pursuing post-secondary education? If so, we encourage you to apply for the Youth Education Award program. 

The aim of the program is to help young brain tumour survivors achieve their dreams through post-secondary education.

Dr. Raymond Reilly was one of our Research Grant recipients in 2019. Since then, Dr. Raymond Reilly and his team have recently obtained some promising results from his research.

His research project aims to develop a new radiation treatment for glioblastoma multiforme (GBM) called a radiation nanomedicine that could be infused at surgery into the brain to eradicate any tumour that the surgeon is unable to remove.

We would like to challenge your lab to participate in our Brain Tumour Walk this year. We feel it is so important not only for the researchers to be surrounded in those they are working to find answers for, yet so important to let those affected in your communities see, that you are there working to find answers for them. 

As your team registers, we encourage you to send a photo of your lab to sruypers@braintumour.ca to feature in our next research newsletter. This will allow all labs to see who is involved and hopefully inspire them to do the same. Heroes supporting Heroes.

Need data for your projects? Check out the registry information for data on survival, prevalence, incidence, and mortality.

The goal of the Brain Tumour Registry of Canada is to routinely provide comprehensive data for all primary brain tumours (malignant and non-malignant) by important patient characteristics (tumour location, histology, sex, age, and region), to better understand the patterns of occurrence and survival.

Brain Canada Foundation and CQDM are joining forces to support interprovincial collaborative translational research and development (R&D) projects on the brain.

This partnership creates a unique funding opportunity that brings together experts from academia and industry to support the development of platforms, tools and biopharmaceuticals that will pave the way for new advances in the prevention, diagnosis and treatment of brain disorders.